Pharmaceuticals

Quadrivalent Market Trends 2025–2029: Forecasts for Key Growth Segments

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Quadrivalent Market Expected To Expand Between 2025 And 2029?

The quadrivalent market size has experienced robust expansion over recent years. It is projected to increase from $8.87 billion in 2024 to $9.51 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.2%. This historical growth can be primarily attributed to factors such as disease complexity, educational initiatives, past health events, healthcare growth, and technological progress.

The quadrivalent market size is projected to experience significant expansion in the upcoming years. It is forecasted to reach $13.91 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.0%. This growth during the forecast period is primarily driven by global health events, competitive dynamics, educational campaigns, regulatory adjustments, and evolving disease patterns. Furthermore, crucial trends for the forecast period include disease prevalence, the regulatory environment, healthcare infrastructure, consumer awareness and education, and the competitive landscape.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9335&type=smp

What Are The Top Growth Drivers Impacting The Quadrivalent Market Outlook?

The increasing occurrence of chronic and infectious diseases is anticipated to boost the expansion of the quadrivalent market. Chronic conditions are long-term illnesses stemming from genetics and lifestyle, whereas infectious diseases are caused by agents such as viruses, bacteria, fungi, or protozoa. Quadrivalent vaccines play a vital role in mitigating morbidity and mortality from severe infections, and also in preventing chronic diseases when infectious agents contribute to their development, for instance, in carcinogenesis. Supporting this trend, a report by the US-based Centers for Disease Control and Prevention in September 2024 revealed that in Week 37, 0.5% of tested specimens were positive for influenza (91.4% influenza A and 8.6% influenza B). Cumulatively since October 1, 2023 (Week 40), 8.7% of specimens tested positive, with 69.2% being influenza A and 30.8% influenza B, indicating an upward trend in overall positivity and a greater proportion of influenza B cases over time. Consequently, the rising prevalence of chronic and infectious diseases is a key factor propelling the growth of the quadrivalent market.

What Are The Primary Types Of Segments Analyzed In The Quadrivalent Market?

The quadrivalent market covered in this report is segmented –

1) By Type: Intradermal Shot, Intramuscular Injection, Nasal Spray

2) By Technology: Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies

3) By Disease: Cancer, Hepatitis, Pneumococcal Disease, COVID-19, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Other Diseases

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospital And Pharmacy, Government Suppliers, Other Channels (NGOs)

Subsegments:

1) By Intradermal Shot: Standard Intradermal Injection, Needle-Free Intradermal Delivery

2) By Intramuscular Injection: Standard Intramuscular Injection, Adjuvanted Intramuscular Injection

3) By Nasal Spray: Live Attenuated Nasal Spray, Inactivated Nasal Spray

Which Key Trends Are Expected To Influence The Quadrivalent Market In The Coming Years?

Product innovations constitute a significant trend gaining traction in the quadrivalent market. Leading companies operating in the quadrivalent market are concentrating on developing inventive solutions to enhance their market standing. For instance, in September 2022, AstraZeneca, a UK-based pharmaceutical company, introduced FluMist quadrivalent (Influenza Vaccination Live, Intranasal), an FDA-approved nasal-spray flu vaccine for individuals aged 2 to 49, which allows for needle-free administration. This product is a live attenuated influenza vaccine (LAIV), accessible in trivalent or quadrivalent forms, and is covered by most health insurance plans as well as the vaccines for children program.

Who Are The Primary Competitors In The Global Quadrivalent Market?

Major companies operating in the quadrivalent market include AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Pfizer Inc., Bio Med Pvt. Ltd., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Emergent BioSolutions Inc., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG)

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

How Does The Quadrivalent Market Perform Across Key Geographic Regions?

North America was the largest region in the quadrivalent market in 2024. The regions covered in the quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Quadrivalent Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9335&type=smp

Browse Through More Reports Similar to the Global Quadrivalent Market 2025, By The Business Research Company

Iot In Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

Power Generators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/power-generators-global-market-report

Ventricular Assist Device Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795